secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRESCENT BIOPHARMA, INC. (CBIO)
CIK:        0001253689
Form:       8-K
Filed at:   2022-01-27T23:59:59+00:00
Accession:  0001558370-22-000516
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

GlycoMimetics awards retention bonuses to CFO, CBO, CSO; induces plan shares to 3M
--------------------------------------------------------------------------------

- CFO Brian Hahn and CBO Armand Girard eligible for retention bonus up to 60% of base salary; CSO John Magnani up to 20%.
- 40% of bonus payable Aug 1, 2022; remaining 60% payable Aug 1, 2023, contingent on continued employment through each date.
- Inducement Plan share reserve increased from 2M to 3M shares to support equity awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1253689/000155837022000516/0001558370-22-000516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1253689/000155837022000516/glyc-20220121x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-000516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer